Neurological manifestation and complications of coronavirus disease 2019: MRI findings

Background Coronavirus disease 2019 (COVID-19) is an infectious disease that commonly manifests in forms that are systemic and/or respiratory. Although less common, some individuals also manifest mild symptoms of gastrointestinal tract or cardiovascular system. We aimed to assess the MRI findings in patients suffering from neurological manifestations after COVID-19. Aim We aimed to assess the MRI findings in patients suffering from neurological manifestations after COVID-19. Patients and methods This study was conducted on 60 patients with clinical criteria of both sexes, with clinical criteria of neurological manifestations after COVID-19 infection. Patients were subdivided in to two groups according to computed tomography (CT) severity index (moderate n =33 and severe n =27), ICU admission (negative n =4 and positive n =56) and white matter changes (negative n =20 and positive n =40). All patients were subjected to radiological assessment by CT scan of the chest and MRI examinations of the brain. Results There was statistically significant higher mean O 2 saturation among cases with moderate CT severity index than cases with severe CT index and higher mean D-dimer among cases admitted to ICU than cases not admitted. There was a statistically significant higher frequency of bilateral lobar involvement, CONSOL among cases with severe than moderate CT severity index, and higher frequency of reticulation among cases admitted to ICU than cases not admitted. Conclusion There may be a link between the neurological development symptoms and a poor prognosis in COVID-19 individuals.